| Mobile Web

Search results for Ars Technica

Industry

Moderna, Merck personalised mRNA cancer vaccine cuts melanoma recurrence or death risk by 42%

A personalised mRNA cancer vaccine being co-developed by Moderna and Merck reduced the risk of recurrence or death in melanoma patients by 42%, the report said. In a phase 3 trial involving 1,137 patients who had tumours removed by surgery, those receiving the vaccine intismeran with Merck\'s Keytruda outperformed a Keytruda-plus-placebo group. The companies are discussing approval procedures with regulators, with detailed results due at a European oncology meeting in Madrid.

Telecommunications & Media

Samsung foldable phone searches jump 460 percent after Apple unveils iPhone Duo

Interest in Samsung Electronics\' foldable phones rose after Apple unveiled its first foldable, the iPhone Duo, with European sales and search volumes climbing, an analysis said. Samsung said its 2026 foldable lineup is selling faster than last year in Europe, with combined sales of the Galaxy Z Fold8 and Fold8 Ultra up 45 percent from the Fold7. In Europe, searches for the Galaxy Z8 series jumped 460 percent week on week.

Industry

Cutting battery demand could reduce emissions more than cleaner manufacturing, study finds

A study suggests cutting demand for electric-vehicle batteries may reduce greenhouse-gas emissions more than improving manufacturing processes. The research team analysed lithium-ion battery emissions for EVs and energy storage systems through 2050, projecting demand could rise as much as 20-fold and supply-chain emissions about 10-fold. Supply-chain measures could cut the per-battery footprint 34 percent by 2050, while demand-management strategies could cut 2024-2050 emissions by 6.0 to 7.2 billion tonnes of CO2 equivalent.